# Sansure Biotech

一家在科创板上市的中国体外诊断企业，已扩大国内即时分子检测的生产与分销产能，持续作为领先的国内 IVD 平台供应商。

Source: https://cn.bioecon.ru/companies/sansure-biotech/
Updated: 2026-07-20

- 国家: China

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 累计融资$7700万 (2018-01-02) | https://www.vcbeathealth.com/article/45360 |
| 营收 | 14.58亿元人民币 (2024-12-31) | https://news.futunn.com/en/post/56123047/sansure-biotech-inc-achieved-a-record-high-in-net-profit, https://www.blackroseband.com/uploadfiles/2025/04/20250429100311990.pdf, https://www.mlznjz.com/uploadfiles/2025/04/20250429102143003.pdf, https://www.moomoo.com/news/post/52250425/sansure-biotech-inc-achieved-a-record-high-in-net-profit |
| 员工人数 | 研发人员581人 (2024-12-31) | https://www.moomoo.com/news/post/52250425/sansure-biotech-inc-achieved-a-record-high-in-net-profit |
| 生产基地 | 长沙产业基地和上海产业基地 (2024-12-31) | http://www.sansureglobal.com/about-sansure/, https://www.sansureglobal.com/about-sansure/ |
| 认证 | ISO 13485、ISO 9001、ISO 15189及CE-IVDR/CE标志认证 | http://www.sansureglobal.com/about-sansure/, https://www.sansureglobal.com/about-sansure/, https://www.sse.com.cn/star/en/marketdata/snapshot/c/5595623.shtml |
| 监管批准 | 超过1,800项国内外注册及批准，包括中国 NMPA 及美国 FDA EUA | http://www.sansureglobal.com/about-sansure/, https://www.lavfund.com/blog/sansure-biotech-debuts-on-star-market, https://www.sse.com.cn/star/en/marketdata/snapshot/c/5595623.shtml, https://www.vcbeathealth.com/article/45360 |

独立来源: blackroseband.com, lavfund.com, mlznjz.com, moomoo.com, news.futunn.com, sansureglobal.com, sse.com.cn, vcbeathealth.com

## 技术

- [即时分子诊断（POC）](https://cn.bioecon.ru/technology/point-of-care-molecular-diagnostics/)